Active Biotech AB (publ)
SSE:ACTI.ST
0.685 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 6.725 | 8.425 | 20.051 | 20.246 | 19.042 | 16.275 | 2.265 | 108.145 | 219.092 | 234.593 | 11.356 | 10.772 | 53.456 | 12.077 | 66.359 | 9.152 | 69.724 | 0.335 | -3.847 |
| Cost of Revenue
| 1.675 | 1.494 | 1.28 | 0 | 0 | 0 | 6.134 | 8.91 | 9.188 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 |
| Gross Profit
| -1.675 | -1.494 | -1.28 | 6.725 | 8.425 | 20.051 | 14.112 | 10.132 | 7.087 | 2.265 | 108.145 | 219.092 | 234.593 | 11.356 | 10.772 | 53.456 | 12.077 | 66.359 | 9.152 | 69.724 | 0.335 | -4.047 |
| Gross Profit Ratio
| 0 | 0 | 0 | 1 | 1 | 1 | 0.697 | 0.532 | 0.435 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1.052 |
| Reseach & Development Expenses
| 32.541 | 42.824 | 34.536 | 25.549 | 28.473 | 39.316 | 49.351 | 58.248 | 176.228 | 221.885 | 308.019 | 375.277 | 318.573 | 217.26 | 212.046 | 207.399 | 189.747 | 46.471 | 55.384 | 239.657 | 284.169 | 285.17 |
| General & Administrative Expenses
| 13.943 | 15.062 | 15.246 | 13.482 | 12.237 | 10.576 | 20.173 | 15.918 | 17.974 | 16.974 | 16.976 | 15.847 | 16.944 | 23.061 | 18.3 | 30.658 | 25.019 | 2.449 | 3.076 | 30.919 | 32.896 | 35.405 |
| Selling & Marketing Expenses
| 12.186 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 12.268 | 15.062 | 15.246 | 13.482 | 12.237 | 10.576 | 20.173 | 15.918 | 17.974 | 16.974 | 16.976 | 15.847 | 16.944 | 23.061 | 18.3 | 30.658 | 25.019 | 2.449 | 3.076 | 30.919 | 32.896 | 35.405 |
| Other Expenses
| 0 | 0 | 0 | 0 | 4.889 | 0 | 0 | 0 | 10.332 | 8.134 | 7.825 | 8.816 | 0 | 0 | 0 | 0 | 0 | 141.863 | 2.102 | -401.704 | -653.167 | -665.735 |
| Operating Expenses
| 44.809 | 57.886 | 49.782 | 39.031 | 40.71 | 49.892 | 69.524 | 74.166 | 194.202 | 238.859 | 324.995 | 391.124 | 335.517 | 240.321 | 230.346 | 238.057 | 214.766 | 190.783 | 142.393 | -131.128 | -336.102 | -345.16 |
| Operating Income
| -46.484 | -57.886 | -49.782 | -32.306 | -32.285 | -29.841 | -102.528 | -55.124 | -177.927 | -228.46 | -209.025 | -163.216 | -100.924 | -228.965 | -219.574 | -184.601 | -202.689 | -124.572 | -133.241 | 200.852 | 336.437 | 341.113 |
| Operating Income Ratio
| 0 | 0 | 0 | -4.804 | -3.832 | -1.488 | -5.064 | -2.895 | -10.933 | -100.865 | -1.933 | -0.745 | -0.43 | -20.162 | -20.384 | -3.453 | -16.783 | -1.877 | -14.559 | 2.881 | 1,004.29 | -88.67 |
| Total Other Income Expenses Net
| 0.684 | -0.486 | -0.043 | 0.061 | -1.847 | -7.037 | -60.619 | -6.668 | 3.52 | 2.874 | 2.556 | 0.079 | -2.616 | -4.657 | -4.403 | 3.977 | -5.029 | -17.401 | -16.102 | -26.624 | -29.45 | -32.79 |
| Income Before Tax
| -45.8 | -58.372 | -49.825 | -32.245 | -34.132 | -36.878 | -109.897 | -61.792 | -184.739 | -233.72 | -214.294 | -171.953 | -103.54 | -233.622 | -223.977 | -180.624 | -207.718 | -141.825 | -149.343 | 174.228 | 306.987 | 308.323 |
| Income Before Tax Ratio
| 0 | 0 | 0 | -4.795 | -4.051 | -1.839 | -5.428 | -3.245 | -11.351 | -103.188 | -1.982 | -0.785 | -0.441 | -20.573 | -20.793 | -3.379 | -17.199 | -2.137 | -16.318 | 2.499 | 916.379 | -80.146 |
| Income Tax Expense
| 0 | 0.319 | 0.058 | -0.128 | 1.934 | -0.067 | -1.104 | -2.208 | 8.792 | -2.208 | -2.208 | 3.062 | -8.99 | -12.557 | 0 | 0.962 | 0 | -2.645 | -13.928 | 348.456 | 0.612 | -9.432 |
| Net Income
| -45.8 | -58.691 | -49.883 | -32.117 | -36.066 | -36.878 | -108.793 | -59.584 | -193.531 | -231.512 | -212.086 | -175.015 | -94.55 | -221.065 | -223.977 | -181.586 | -207.718 | -139.18 | -135.415 | -174.228 | -307.599 | -298.891 |
| Net Income Ratio
| 0 | 0 | 0 | -4.776 | -4.281 | -1.839 | -5.374 | -3.129 | -11.891 | -102.213 | -1.961 | -0.799 | -0.403 | -19.467 | -20.793 | -3.397 | -17.199 | -2.097 | -14.796 | -2.499 | -918.206 | 77.695 |
| EPS
| -0.17 | -0.23 | -0.2 | -0.19 | -0.18 | -0.22 | -0.72 | -0.4 | -1.29 | -1.7 | -1.58 | -1.43 | -0.78 | -1.9 | -2.14 | -2.06 | -2.18 | -1.7 | -1.75 | -2.37 | -5.43 | -10.75 |
| EPS Diluted
| -0.17 | -0.23 | -0.2 | -0.19 | -0.18 | -0.22 | -0.72 | -0.4 | -1.29 | -1.7 | -1.58 | -1.43 | -0.78 | -1.9 | -2.14 | -2.06 | -2.18 | -1.56 | -1.59 | -2.37 | -5.43 | -10.75 |
| EBITDA
| -44.809 | -56.352 | -48.489 | -31.053 | -31.331 | -29.365 | 7.068 | -43.057 | -165.716 | -216.443 | -197.143 | -153.492 | -76.945 | -227.104 | -213.273 | -184.601 | -202.689 | -102.471 | -109.191 | 204.69 | 341.698 | 346.552 |
| EBITDA Ratio
| 0 | 0 | 0 | -4.618 | -3.719 | -1.465 | 0.349 | -2.261 | -10.182 | -95.56 | -1.823 | -0.701 | -0.328 | -19.999 | -19.799 | -3.453 | -16.783 | -1.544 | -11.931 | 2.936 | 1,019.994 | -90.084 |